Lazard Inc (LAZ) is not a strong buy at the moment for a beginner investor with a long-term focus. While there are some positive catalysts such as analyst optimism and a diversified business model, the technical indicators, financial performance, and options sentiment suggest caution. The stock's recent financial performance shows declining net income and EPS, and technical indicators do not signal a strong entry point. For a long-term investor, it may be better to wait for clearer signs of growth or a more favorable entry point.
The MACD is negative and expanding downward, indicating bearish momentum. The RSI is neutral at 21.531, and moving averages are converging, suggesting no clear trend. The stock is trading near a key support level (S1: 46.837) but remains below the pivot point (49.876), showing limited upward momentum.

Analyst upgrades from UBS and Keefe Bruyette with price targets raised to $59 and $62, respectively. BofA initiated coverage with a Buy rating and a $65 price target, citing a diversified business model and potential cyclical tailwinds in M&A activity.
Declining financial performance in Q4 2025, with net income down -42.71% YoY and EPS down -43.75% YoY. No significant hedge fund or insider activity. Bearish technical indicators and options sentiment.
In Q4 2025, revenue increased by 6.80% YoY, but net income dropped significantly by -42.71% YoY, and EPS fell by -43.75% YoY. Gross margin slightly improved to 97.48%. Overall, financial performance shows mixed results with declining profitability.
Analysts are mixed but leaning positive. Recent upgrades include UBS raising the price target to $59 and Keefe Bruyette to $62, with BofA initiating coverage with a Buy rating and a $65 price target. However, Morgan Stanley maintains an Underweight rating with a reduced price target of $59.